Active ingredientAleglitazarCat. No. P-A070-001CAS 475479-34-6Family · Pharmaceutical analytical standards
Aleglitazar
A dual PPAR-alpha and PPAR-gamma agonist, designed for type 2 diabetes to improve both blood lipids and insulin sensitivity; its phase III studies were stopped in 2013. This family brings together the active ingredient.
Did you know?The large AleCardio study enrolled more than 7,200 diabetic patients after an acute coronary syndrome: it improved glycated haemoglobin, triglycerides and HDL cholesterol, but did not reduce cardiovascular events.
Go to the active ingredient →Active ingredientAleglitazarCat. No. P-A070-001CAS 475479-34-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.